---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-146454"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:46:28.295948+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Finch Therapeutics receives Nasdaq delisting notice; trading suspended May 28

## Summary
- Nasdaq Listing Panel determined to delist Finch; company deemed a 'public shell' without an operating business.
- Trading of common stock suspended at opening on May 28, 2024; Nasdaq will file Form 25-NSE after 45 days.
- Common stock expected to trade on OTC market, but no assurance of prompt or continued trading.

## SEC filing metadata
- accession: 0001193125-24-146454
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000119312524146454/0001193125-24-146454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000119312524146454/d818218d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-146454
- JSON: https://secwatch.observer/filing/0001193125-24-146454.json
- Plain text: https://secwatch.observer/filing/0001193125-24-146454.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.